The treatment of spasticity by intrathecal administration of baclofen: A preliminary personal experience

G. Broggi, D. Servello, S. Brock, I. Dones

Research output: Contribution to journalArticle


The administration of baclofen, a GABAb agonist, by direct infusion into the CSF by means of a programmable device, may avoid the undesired side effects of the oral administration of both the same and other antispastic drugs while giving a marked reduction of spasticity. The preliminary results on 12 patients show the total efficacy of this procedure in reducing spasticity markedly.

Original languageEnglish
Pages (from-to)203-208
Number of pages6
JournalJournal of Neurosurgical Sciences
Issue number4
Publication statusPublished - 1993



  • baclofen
  • spasticity

ASJC Scopus subject areas

  • Clinical Neurology

Cite this